首页> 外文期刊>European Journal of Clinical Pharmacology >Physician, organisational and patient characteristics explaining the use of angiotensin converting enzyme inhibitors in heart failure treatment: a multilevel study
【24h】

Physician, organisational and patient characteristics explaining the use of angiotensin converting enzyme inhibitors in heart failure treatment: a multilevel study

机译:医师,组织和患者的特征解释了血管紧张素转化酶抑制剂在心力衰竭治疗中的用途:一项多层次研究

获取原文
获取原文并翻译 | 示例
           

摘要

Heart failure treatment in general practice is not concordant with guideline recommendations. Insight into the key determinants at different levels is needed in order to improve care. The aim was to assess the influence of physician, organisational and patient characteristics on the treatment of chronic heart failure with angiotensin converting enzyme (ACE) inhibitors in primary care.
机译:一般实践中,心力衰竭的治疗与指南的建议不一致。为了改善护理水平,需要深入了解不同级别的关键决定因素。目的是评估医师,组织机构和患者特征对在初级保健中使用血管紧张素转化酶(ACE)抑制剂治疗慢性心力衰竭的影响。

著录项

  • 来源
    《European Journal of Clinical Pharmacology》 |2005年第2期|145-151|共7页
  • 作者单位

    Department of Clinical Pharmacology University of GroningenNorthern Centre for Healthcare Research University of Groningen;

    Department of Clinical Pharmacology University of GroningenDepartment of Clinical Pharmacology University of GroningenNorthern Centre for Healthcare Research University of Groningen;

    Northern Centre for Healthcare Research University of GroningenDepartment of Health Sciences University of Groningen;

    Department of Clinical Pharmacology University of GroningenDepartment of Internal Medicine Groningen University Hospital;

    Department of Clinical Pharmacology University of GroningenNorthern Centre for Healthcare Research University of Groningen;

  • 收录信息
  • 原文格式 PDF
  • 正文语种 eng
  • 中图分类
  • 关键词

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号